Sagging tissue along the jawline—commonly referred to as jowls—is one of the most prominent signs of lower-face aging. When patients notice these early signs of laxity, their initial question is almost always: How do I get rid of jowls without surgery?
In response, the medical aesthetics market offers an array of energy-based devices, dermal fillers, and thread lifts. While these non-surgical modalities are highly effective for mild laxity, they are often over-promised to patients with moderate-to-severe skin excess who are anatomically suited only for a surgical facelift.
This guide provides a severity-graded decision framework, analyzing the biological mechanisms of jowl formation, the FDA clearance records and safety profiles of skin-tightening devices, the role of strategic injectables, the impact of GLP-1 weight-loss medications ("Ozempic face"), and the anatomical limits that define the surgical threshold.
1. What Actually Causes Jowls — Loose Skin, Volume Loss, or Both?
Anatomically, jowl formation is not a simple skin problem; it is the result of structural changes across bone, ligaments, fat compartments, and the skin envelope.
Pathophysiology of Jowl Formation:
┌────────────────────────────────────────────────────────┐
│ 1. Skin Dermal Layer (Collagen / Elastin Depletion) │
├────────────────────────────────────────────────────────┤
│ 2. Retaining Ligaments (Zygomatic / Masseteric Laxity) │
├────────────────────────────────────────────────────────┤
│ 3. Midface Fat Compartments (Malar / Deep Atrophy) │
├────────────────────────────────────────────────────────┤
│ 4. Accumulation at the Mandibular / Pre-jowl Border │
└────────────────────────────────────────────────────────┘
The Retaining Ligaments of the Face
The soft tissues of the face are anchored to the underlying bone by rigid fibrous bands called retaining ligaments. The two primary ligaments governing the lower face are the zygomatic cutaneous ligament (which supports the cheek) and the masseteric cutaneous ligament (which supports the lateral cheek and jawline).
With age, these ligaments undergo gradual elongation and laxity. As they loosen, they fail to support the overlying soft tissues, allowing the superficial fat pads of the midface to slide downward and forward under the influence of gravity.
Fat Compartment Re-distribution
The midface fat pads (malar and deep medial cheek fat) undergo progressive atrophy (deflation) as part of the normal aging process. This loss of superior volume removes the physical scaffold that holds the lower facial tissues taut.
Simultaneously, the submandibular fat compartments in the lower face tend to hypertrophy or descend, accumulating directly above the mandibular border. Because the mandibular ligament acts as a fixed anchor near the chin, the descending tissue spills over this ligamentous boundary, forming the visible projection known as a jowl.
Dermal Thinning and Elastin Degradation
Concurrently, the dermal layer of the skin undergoes a steady decline in Type I and Type III collagen (which provides tensile strength) and elastin (which provides elastic recoil). This thinning of the skin envelope reduces its capacity to contain and support the descending fat pads, accelerating the transition from mild jawline softening to prominent jowling.
2. Ultherapy (and Ultherapy PRIME), Sofwave, RF, and Morpheus8 — Which Devices Help Mild Jowls?
For patients with mild jawline laxity who retain good dermal elasticity, energy-based devices aim to stimulate neocollagenesis by delivering controlled thermal damage to specific tissue layers.
Microfocused Ultrasound: Targeting the SMAS (Ultherapy vs. Sofwave)
Microfocused ultrasound (MFU) is the primary non-surgical modality cleared to target the deep structural layer of the face: the Superficial Muscular Aponeurotic System (SMAS). The SMAS is a continuous fibromuscular sheath that connects the facial muscles to the overlying skin and is the same structural layer that surgeons imbricate and lift during a facelift.
- Ultherapy (Ulthera, Inc.): Originally cleared by the FDA on August 28, 2012 (510(k) K122528) for non-invasive lifting of the submental tissue, neck, and brow under product code OHV (focused ultrasound). The platform has evolved, culminating in the Ulthera System (UC-1 Control Unit PRIME Model 2.1), cleared May 13, 2025 (510(k) K250418), which extended the platform's indications to the body (abdomen and arms). Throughout the Ulthera lineage the device has paired micro-focused ultrasound with real-time visualization (branded MFU-V) via its DeepSEE transducer, which images tissue down to roughly 8 mm so the operator can place thermal coagulation zones directly into the SMAS at treatment depths up to 4.5 mm. MFU-V heating reaches temperatures between 60°C and 70°C, triggering collagen denaturation and subsequent remodeling.
- Sofwave (Sofwave Medical, Ltd.): Cleared by the FDA on August 28, 2023 (510(k) K231537) for non-invasive dermatological aesthetic treatments to improve facial lines and wrinkles and lift the eyebrow, submental, and neck tissues. Sofwave utilizes Synchronous Ultrasound Parallel Beam (SUPERB) technology, which delivers seven parallel cylindrical acoustic zones to a depth of 1.5 mm (mid-dermis). It heats the tissue to 60–70°C to stimulate collagen synthesis but does not reach the deep SMAS layer.
Radiofrequency (RF) Resurfacing and Microneedling (Morpheus8 vs. Thermage)
Radiofrequency energy heats the tissue via electrical resistance, targeting the dermis and subdermal fat.
- Morpheus8 (Inmode Ltd.): An RF microneedling device cleared under product code OUH (electrosurgical microneedle). It uses insulated needles to deliver bipolar RF energy at variable depths (up to 4 mm in the face, with an additional 1 mm thermal profile), allowing for targeted coagulation of subdermal adipose tissue (subdermal adipose remodeling) alongside dermal collagen contraction. Morpheus8 is highly effective for patients with mild jowls combined with submental fullness, as it can gently reduce fat volume while tightening the skin.
- Thermage FLX (Solta Medical): A monopolar, non-invasive RF device that delivers bulk heating to the deep dermis and fibrous septae, promoting immediate collagen contraction followed by long-term collagen synthesis.
Safety Grounding: Focused-Ultrasound Adverse Events
While these non-invasive devices carry lower risk profiles than surgery, post-market surveillance is crucial. In our inspection of the FDA MAUDE database under focused-ultrasound product code OHV (which logged 223 adverse event reports), the clinical distribution was:
- Ulthera-branded devices: 160 reports (including burns, localized nerve bruising causing temporary facial asymmetry, and fat atrophy).
- Sofwave-branded devices: 16 reports (predominantly minor skin burns or blistering).
This data underscores the importance of proper operator training and energy delivery, as excessive energy or incorrect depth selection can lead to tissue damage or nerve irritation.
3. Can Filler Fix Jowls — Midface Re-support, Jawline Definition (Volux), and the Nefertiti Lift?
Dermal fillers are frequently utilized to address jowls. However, filler does not lift tissues; instead, it camouflages the shadows created by sagging tissue or re-supports the midface from above.
The Midface Anchor: Volumizing the Vector
If a patient has mild jowling secondary to cheek deflation, injecting a highly cohesive HA filler like Juvéderm Voluma XC into the supraperiosteal plane of the zygomatic arch can restore the lost superior volume. This lateral and superior vector of support can pull the lower cheek tissues upward, softening early jowling.
Camouflaging the Pre-Jowl Sulcus with Volux
As jowls form, a depression (sulcus) develops between the chin and the sagging cheek tissue, known as the pre-jowl sulcus. Injecting filler directly into this depression can align the jawline contour, camouflaging the appearance of the jowl.
- Juvéderm Volux XC: Approved by the FDA in 2022 under PMA P110033/S065, Volux XC is the first hyaluronic acid dermal filler indicated for deep injection (subcutaneous and/or supraperiosteal) to improve moderate to severe loss of jawline definition in adults over 21. Volux is a highly rigid filler with a high elastic modulus (G') and high cohesivity, allowing it to mimic bony structure along the mandibular border and resist displacement by overlying tissues.
The Nefertiti Lift: Neurotoxins for the Platysma
For patients with early jowling exacerbated by hyperactive muscles, the Nefertiti Lift uses botulinum toxin injections along the jawline and into the platysma bands. The platysma is a superficial muscle that wraps the neck and inserts into the lower border of the mandible, acting as a depressor that pulls the lower face downward. Relaxing the lateral bands of the platysma allows the upward-pulling facial muscles (levators) to act unopposed, lifting the jawline contour.
4. Thread Lifts for Jowls — Real Lift or Temporary Stitch?
Thread lifts use temporary sutures inserted subcutaneously to physically elevate and reposition sagging soft tissues.
Thread Lift Elevation Mechanism:
┌────────────────────────────────────────────────────────┐
│ 1. Insertion of Cannula (Subcutaneous / Deep Dermis) │
├────────────────────────────────────────────────────────┤
│ 2. Engagement of Barbs/Cogs into Descended Adipose │
├────────────────────────────────────────────────────────┤
│ 3. Mechanical Suspension & Anchoring to Stable Fascia │
├────────────────────────────────────────────────────────┤
│ 4. Dissolution of PDO (6-9 Months) & Collagen Scaffold │
└────────────────────────────────────────────────────────┘
Mechanical Suspension vs. Biological Remodeling
Typically, polydioxanone (PDO), poly-L-lactic acid (PLLA), or polycaprolactone (PCL) threads feature molded barbs or cogs. The surgeon inserts these threads via a cannula into the subcutaneous fat, engages the barbs into the descended adipose tissue, and pulls the thread superiorly to anchor the tissue to stable fascia (typically the temporoparietal fascia).
This mechanical suspension provides an immediate lift. However, the mechanical lifting force begins to decay within weeks as the soft tissues stretch and settle. The long-term efficacy relies on biological remodeling: as the PDO thread degrades via hydrolysis over 6 to 9 months, it leaves behind a localized scaffold of newly synthesized Type I collagen that maintains a mild tightening effect.
Durability Evidence
Clinical data indicates that thread lifts are the least durable lifting option. Our evaluation of thread-lift durability suggests that visible tissue elevation typically persists for 6 to 12 months. Common complications include thread extrusion, visible puckering of the skin, localized infection, and asymmetry. For patients seeking multi-year correction, thread lifts generally under-deliver.
5. The Fibrosis Caveat: Non-Surgical Heat and Subsequent Surgical Dissection
A critical clinical factor that patients are rarely informed about when selecting energy-based skin tightening is the biological consequence of delivering repetitive high-temperature thermal energy to the deep tissue planes.
Thermal Fibrosis and Tissue Plane Obliteration
Devices like Ultherapy and Morpheus8 achieve skin tightening by delivering high thermal energy (60°C to 70°C) into the deep dermis, subcutaneous fat, and SMAS. While this thermal energy successfully triggers collagen contraction and deposition, the tissue heals via a process of micro-scarring (subdermal fibrosis).
Over multiple treatment sessions separated by 12 to 24 months, this micro-scarring accumulates, gradually obliterating the natural anatomical glide planes between the skin, the subcutaneous fat, and the SMAS.
Impact on Subsequent Facelift Surgery
When a patient eventually transitions from non-surgical devices to a surgical facelift, this accumulated scar tissue presents significant challenges for the plastic surgeon:
- Challenging Dissection: The surgeon relies on clean tissue planes to safely separate the skin and fat from the underlying SMAS and deep structures. In patients with severe thermal fibrosis, these planes are fused. The surgeon must perform sharp dissection under tension, which increases operating times.
- Increased Nerve Risk: The facial nerve branches lie directly beneath the SMAS. When the SMAS is scarred and fused to the overlying tissue due to previous microfocused ultrasound or RF energy, identifying and preserving these nerve branches is more difficult, which increases the risk of temporary or permanent facial paralysis.
- Compromised Flap Mobility: Scarred SMAS tissue is less pliable and more brittle, reducing the surgeon's ability to pull and anchor it into a superior-posterior position with optimal tension.
Practitioners should counsel patients that while non-surgical devices are excellent for delaying surgery, excessive and repetitive treatments can make subsequent surgical correction more difficult — a parallel to the way long-term filler can complicate a future facelift, which we examine in our guide on years of filler and their consequences for a future facelift.
6. When Is a Facelift (or Mini-Lift) the Only Real Option for Jowls?
For patients with moderate-to-severe jowling, non-surgical options are anatomically contraindicated. When excess skin has accumulated along the jawline, continuing to add filler or energy-based tightening will not yield a satisfactory result.
The Anatomical Limits of Non-Surgical Lifting
Energy-based devices (Ultherapy, Sofwave, Morpheus8) can shrink skin tissue by approximately 10% to 15% through thermal contraction. When a patient has more than 1 to 2 centimeters of excess skin fold along the mandibular border, this tissue cannot be resolved by non-surgical tightening. Adding dermal fillers to camouflage severe jowls will widen the lower face, converting a saggy jawline into a bulky, masculine jawline.
Facelift Modalities: SMAS vs. Deep Plane
A surgical facelift (rhytidectomy) is the definitive corrective procedure, and we compare the techniques, recovery, and cost in our guide to facelift types, cost, and recovery.
- SMAS Plication/Ectomy: The surgeon lifts the skin, exposes the underlying SMAS, pulls the SMAS superiorly and posteriorly, and either folds (plicates) or cuts and sutures (ectomizes) the excess SMAS tissue.
- Deep Plane Facelift: The surgeon dissects beneath the SMAS layer, releasing the deep retaining ligaments (including the zygomatic and masseteric ligaments) that anchor the facial tissues. This allows the surgeon to lift the entire composite flap of muscle and fat as a single unit without tension on the skin, providing a more natural and long-lasting restoration of the jawline and midface.
Surgical Statistics and Fees
According to the ASPS 2024 Plastic Surgery Statistics Report, surgical rejuvenation remains highly sought-after, with 15,978 facelifts performed by ASPS member surgeons in 2024, a 20% year-over-year increase (ASPS restructured its 2024 methodology to report verified member-surgeon counts rather than the extrapolated national estimates used in prior years).
The ASPS 2023 national average surgeon fee for a facelift is $11,395 (representing the surgeon's fee only). When anesthesia, operating room facilities, and surgical supplies are factored in, the all-in cost ranges from $15,000 to $35,000. A facelift typically provides a restoration that lasts 7 to 10 years.
7. Does "Ozempic Face" From GLP-1 Weight Loss Make Jowls Worse?
The rapid adoption of GLP-1 receptor agonists (such as semaglutide and tirzepatide) for weight loss has introduced a new patient population to clinical aesthetic practices.
Fat Pad Deflation and Ligament Stress
Rapid weight loss causes a rapid depletion of the superficial and deep fat compartments of the face, including the deep medial cheek fat pad. This rapid deflation removes the physical support that maintains tension on the retaining ligaments.
As a result, the ligaments experience sudden mechanical stress, and the overlying skin—which may already have reduced elasticity—sags rapidly, accelerating the formation of prominent jowls. This clinical presentation is often referred to as "Ozempic face," which we cover in detail in our guide to GLP-1 "Ozempic face" treatments.
The Surge in Non-Surgical and Surgical Demand
The rapid uptake of GLP-1 medications has driven a noticeable increase in patient inquiries to aesthetic practices, and demand splits into two phases:
- Early Weight-Loss Phase: Patients experiencing early facial deflation seek immediate volume restoration via dermal fillers and skin tightening via Ultherapy or Sofwave to arrest the sagging process.
- Post-Weight-Loss Phase: Patients who have achieved significant weight loss and are left with severe skin laxity are directed straight to surgical intervention (facelifts and neck lifts), as non-surgical devices cannot contract the expanded skin envelope.
8. Decisional Triage Matrix: Selecting the Right Jowl Intervention
| Clinical Presentation | Severity | Primary Anatomical Deficit | Recommended Modality | Expected Longevity | Cost Range (All-In) |
|---|---|---|---|---|---|
| Early jawline softening, good skin elasticity, minimal descent | Mild | Early dermal collagen loss, superficial laxity | MFU (Ultherapy/PRIME) or Sofwave | 12 to 24 months | $1,500 – $3,500 |
| Localized hollows, pre-jowl shadowing, cheeks deflated but skin firm | Mild to Moderate | Deep fat pad atrophy, skeletal recession | Strategic Cheek/Jawline Filler (Voluma, Volux) | 12 to 24 months | $1,400 – $4,800 |
| Jawline laxity with submental fullness, mild fat accumulation | Mild to Moderate | Subdermal fat descent + skin laxity | RF Microneedling (Morpheus8) | 12 to 18 months | $2,000 – $4,500 |
| Early jowling, patient desires immediate mechanical repositioning | Moderate | Soft-tissue descent with mild skin excess | PDO Thread Lift + Biostimulator (Sculptra) | 6 to 12 months | $2,500 – $6,000 |
| Prominent jowling, distinct pre-jowl sulcus, excess skin fold | Moderate to Severe | Retaining ligament laxity + skin envelope expansion | Surgical Mini-Facelift or SMAS Facelift | 7 to 10 years | $15,000 – $25,000+ |
| Severe jowling, skin pooling at jawline, neck laxity, GLP-1 deflation | Severe | Complete loss of structural support + severe skin excess | Deep Plane Facelift + Neck Lift + Fat Grafting | 10+ years | $20,000 – $35,000+ |
FAQ
How do I know if my jowls are mild enough for Ultherapy or whether I already need a facelift?
A simple clinical test is the finger-lift assessment. Place two fingers over your cheekbones and apply a gentle upward and posterior pull. If this minor traction completely resolves your jowls and smooths your jawline, your laxity is mild to moderate, and you are likely a good candidate for microfocused ultrasound (Ultherapy/Sofwave) or strategic dermal fillers. If, however, pulling the tissue leaves a large fold of excess skin in front of your ears or does not resolve the sagging along the jawline, you have excess skin that requires surgical excision via a facelift.
Will filler actually lift my jowls or just make my face look wider?
Dermal filler does not possess the mechanical lifting force to lift descended tissue. It can only restore volume to the cheeks (to create a visual lift) or fill the pre-jowl sulcus (to camouflage the jowl). If you have significant skin laxity, injecting filler into the lower face will not lift the jowls; it will simply add volume to an already heavy area, making your face look wider and heavier. If laxity is your primary concern, filler is the wrong choice.
How does the cost of years of Ultherapy and filler compare to a one-time facelift?
While non-surgical treatments are cheaper up front, their cumulative cost accumulates over time. For example, getting annual cheek and jawline fillers ($2,000/year) and a skin-tightening treatment every two years ($2,500, or $1,250/year) results in a cumulative spend of approximately $16,250 over 5 years and $32,500 over 10 years. This cumulative cost is equivalent to or exceeds the cost of a surgical facelift, which provides a more comprehensive, longer-lasting result.
I lost a lot of weight on a GLP-1 and now have sagging jowls — what is the right sequence of treatments?
If you are currently losing weight on a GLP-1 medication, you should wait until your weight has stabilized for at least 3 to 6 months before undergoing definitive treatment. Undergoing a facelift or fat grafting while still actively losing weight can result in further deflation, compromising your surgical results. While losing weight, you can support your skin quality with non-invasive energy devices (like Ultherapy or RF microneedling). Once your weight is stable, a plastic surgeon can evaluate whether you require volume restoration (fat grafting/fillers), structural lifting (facelift), or a combination of both.
Sources
- American Society of Plastic Surgeons (ASPS): 2024 Plastic Surgery Statistics Report. Sourced from: https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf
- American Society of Plastic Surgeons (ASPS): 2023 Plastic Surgery Statistics Report. Sourced from: https://www.plasticsurgery.org/documents/news/statistics/2023/plastic-surgery-statistics-report-2023.pdf
- Food and Drug Administration (FDA): 510(k) Clearance for Ulthera System (UC-1 Control Unit PRIME Model 2.1). 510(k) Number: K250418. Sourced from: https://www.accessdata.fda.gov/cdrh_docs/pdf25/K250418.pdf
- Food and Drug Administration (FDA): 510(k) Clearance for SofWave System. 510(k) Number: K231537. Sourced from: https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231537.pdf
- National Institutes of Health (NIH): Advances in Anti-aging Procedures: A Comprehensive Review of Surgical and Non-surgical Rejuvenation Techniques (2025). PMC12535610. Sourced from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12535610
- Sinno, S., et al. (ASPS Member Survey): Most Plastic Surgeons Now Use Fat Grafting as Part of Facelift Surgery. Sourced from: https://www.plasticsurgery.org/news/press-releases/most-plastic-surgeons-now-use-fat-grafting-as-part-of-facelift-surgery
- Business Insider (Aug 2025): Skin Tightening Procedures Might Take Over Facelift Trend. Sourced from: https://www.businessinsider.com/skin-tightening-treatments-ultherapy-red-light-sofwave-facelift-alternatives-2025-8
